Table 2.
Target genes of 15 dysregulated miRNA were selected for RT-PCR examination in this study
| Target type | Group | Gene Symbol | miRNA | Expression level in colon cancer# |
|---|---|---|---|---|
| predicted | Group I | GDNF | miR133a, miR9 | Down** |
| miRNA ↓ | MYH9 | miR133a, miR9 | Up* | |
| RNF111 | miR1, miR9 | Down* | ||
| GroupII | GNA13 | miR182, miR96 | Down* | |
| miRNA ↑ | HBEGF | miR182, miR96 | Down*** | |
| LAMC1 | miR182, miR96 | Up*** | ||
| PPP2R3A | miR182, miR96 | Down*** | ||
| known | Group III | Bim | miR10b | NS |
| miRNA ↓ | CDC42 | miR1 | NS | |
| collagen I | miR143 | Up*** | ||
| CyclinD1 | miR1 | Up** | ||
| PDGFRB | miR9 | NS | ||
| PPP2CA | miR133 | NS | ||
| Versican | miR9 | Up** | ||
| calmodulin | miR196a, miR143 | NS | ||
| Group IV | ATM | miR18a | NS | |
| miRNA ↑ | FBXW7 | miR182 | NS | |
| FZD3 | miR31, miR182 | NS | ||
| SMAD2 | miR18a | Up** | ||
| Group V | CREB1 | miR10b, miR182 | Up*** | |
| FBXW11 | miR133, miR96, miR182 | NS | ||
| Mixed | IGF1 | miR1, miR18a | Down*** | |
| MAP3K14 | miR137, miR31 | NS | ||
| MSN | miR133a, miR96 | Up*** | ||
| PDGFRA | miR342, miR182 | NS | ||
| SMAD4 | miR1, miR224 | NS | ||
| RASA1 | miR1, miR96, miR182, miR31 | NS | ||
# Paired t test results: NS: not significant, * P < 0.05, ** P <0.01, *** P < 0.001